• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Polaryx Announces FDA Grants Orphan Drug Designation for PLX-200

    PRNEWSWIRE

    Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug

    PRNEWSWIRE

    Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan

    PRNEWSWIRE

    Polaryx Receives Both Rare Pediatric Disease and Orphan Drug Designations

    PRNEWSWIRE

    Polaryx Receives Both Rare Pediatric Disease and Orphan Drug Designations

    PRNEWSWIRE

    Polaryx Receives Both Rare Pediatric Disease and ODD

    PRNEWSWIRE

    Polaryx Receives Both Rare Pediatric Disease and Orphan Drug Designations

    PRNEWSWIRE

    Polaryx Therapeutics Receives FDA Fast Track Designation to PLX-200

    PRNEWSWIRE

    Polaryx Therapeutics Receives IND Approval From the FDA to Study PLX-200

    PRNEWSWIRE

    Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA

    PR NEWS WIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.